FDA Inspection 1009371 - 3D Imaging Drug Design and Development - April 20, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns 3D Imaging Drug Design and Development, with an inspection on April 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: 3D Imaging Drug Design and Development
Inspection Date: April 20, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · c6f3d6f1-1f20-4260-8e56-e2dbb100d33a

Violation Codes10

21 CFR 212.20(d)21 CFR 212.20(e)21 CFR 212.30(a)21 CFR 212.30(b)21 CFR 212.40(c)21 CFR 212.5021 CFR 212.50(b)21 CFR 212.60(b)21 CFR 212.60(f)21 CFR 314.80(b)

Full citation text and observation details available on the Dashboard.